“I was ruining the time that I had”
When 15-year-old Amaria Granger received a diagnosis of Neimann-Pick type C—a rare, fatal neurodegenerative disorder—nearly six years ago, her mother, Mandy Baxter, exhausted financial resources exploring every possible avenue to slow down its progression. Known as "childhood Alzheimer’s," the disease lacks a cure, yet Mandy spent years attempting various treatments to save her daughter. They even faced a period of homelessness after participating in an experimental drug trial, requiring frequent trips from Pueblo, Colo., to Chicago every two weeks in the hope of slowing the disease's progress. Unfortunately, nothing proved effective.
Mandy’s hopes rose, again, in 2020, when she read that researchers were studying Niemann-Pick as a part of the search for a Covid-19 vaccine. When nothing came to fruition, and she realized how much time they had lost to the pandemic, her mindset began to change.
More and more, her mind kept drifting back to a conversation she’d had with a more-seasoned Niemann-Pick mom soon after Amaria was diagnosed.
This mother no longer called an ambulance at every seizure or pursued every clinical trial. She wasn't engaging in all the activities Mandy was. As time passed and Amaria continued to progress, Mandy grasped the rationale behind her approach. She recognized the moment when quantity became the adversary of quality, shifting her focus from extending Amaria's life to enhancing the quality of the life she has left.
Now, with the assistance of her twin sons, Silas and Marcus Swint, 25, they fulfill all of Amaria's home health needs and strive to provide her with as many meaningful experiences as possible during this time.